Annual CFO
$1.26 B
+$222.57 M+21.50%
December 31, 2022
Summary
- As of February 7, 2025, HZNP annual cash flow from operations is $1.26 billion, with the most recent change of +$222.57 million (+21.50%) on December 31, 2022.
- During the last 3 years, HZNP annual CFO has risen by +$831.51 million (+195.04%).
Performance
HZNP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
$161.47 M
+$75.14 M+87.05%
June 30, 2023
Summary
- As of February 7, 2025, HZNP quarterly cash flow from operations is $161.47 million, with the most recent change of +$75.14 million (+87.05%) on June 30, 2023.
- Over the past year, HZNP quarterly CFO has dropped by -$87.73 million (-35.21%).
Performance
HZNP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
$1.04 B
-$87.73 M-7.77%
June 30, 2023
Summary
- As of February 7, 2025, HZNP TTM cash flow from operations is $1.04 billion, with the most recent change of -$87.73 million (-7.77%) on June 30, 2023.
- Over the past year, HZNP TTM CFO has dropped by -$373.94 million (-26.43%).
Performance
HZNP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
HZNP Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.5% | -35.2% | -26.4% |
| 3 y3 years | +195.0% | +62.1% | +229.4% |
| 5 y5 years | +342.4% | +161.3% | +144.1% |
HZNP Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -17.7% | -70.0% | -46.5% | -26.4% | -0.5% |
| 5 y | 5-year | at high | -66.1% | -70.0% | -138.8% | -26.4% | -70.4% |
| alltime | all time | at high | -106.1% | -70.0% | -143.8% | -26.4% | -107.6% |
Horizon Therapeutics Public Limited Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $161.47 M(+87.0%) | $1.04 B(-7.8%) |
| Mar 2023 | - | $86.32 M(-79.8%) | $1.13 B(-10.3%) |
| Dec 2022 | $1.26 B(+21.5%) | $426.39 M(+16.4%) | $1.26 B(-8.2%) |
| Sep 2022 | - | $366.46 M(+47.1%) | $1.37 B(-3.2%) |
| Jun 2022 | - | $249.20 M(+15.5%) | $1.41 B(+12.7%) |
| Mar 2022 | - | $215.79 M(-59.9%) | $1.25 B(+21.2%) |
| Dec 2021 | $1.04 B(+86.3%) | $538.56 M(+31.0%) | $1.04 B(+14.2%) |
| Sep 2021 | - | $411.04 M(+359.8%) | $906.53 M(+50.0%) |
| Jun 2021 | - | $89.40 M(-2498.1%) | $604.35 M(-1.7%) |
| Mar 2021 | - | -$3.73 M(-100.9%) | $614.55 M(+10.6%) |
| Dec 2020 | $555.69 M(+30.3%) | $409.82 M(+276.5%) | $555.69 M(+64.8%) |
| Sep 2020 | - | $108.86 M(+9.3%) | $337.25 M(+6.8%) |
| Jun 2020 | - | $99.60 M(-259.1%) | $315.90 M(+2.7%) |
| Mar 2020 | - | -$62.59 M(-132.7%) | $307.57 M(-27.9%) |
| Dec 2019 | $426.33 M(+119.1%) | $191.38 M(+118.7%) | $426.33 M(+24.1%) |
| Sep 2019 | - | $87.52 M(-4.1%) | $343.66 M(+0.8%) |
| Jun 2019 | - | $91.27 M(+62.5%) | $341.00 M(+9.5%) |
| Mar 2019 | - | $56.17 M(-48.3%) | $311.52 M(+60.1%) |
| Dec 2018 | $194.54 M(-31.6%) | $108.71 M(+28.1%) | $194.54 M(-15.1%) |
| Sep 2018 | - | $84.86 M(+37.3%) | $229.09 M(+7.8%) |
| Jun 2018 | - | $61.78 M(-201.6%) | $212.58 M(+7.0%) |
| Mar 2018 | - | -$60.81 M(-142.4%) | $198.72 M(-30.1%) |
| Dec 2017 | $284.34 M(-23.0%) | $143.26 M(+109.6%) | $284.34 M(+1.5%) |
| Sep 2017 | - | $68.35 M(+42.6%) | $280.26 M(-17.7%) |
| Jun 2017 | - | $47.92 M(+93.2%) | $340.70 M(+0.2%) |
| Mar 2017 | - | $24.81 M(-82.2%) | $340.08 M(-8.0%) |
| Dec 2016 | $369.46 M | $139.19 M(+8.1%) | $369.46 M(+1.2%) |
| Sep 2016 | - | $128.79 M(+172.3%) | $365.21 M(+12.4%) |
| Jun 2016 | - | $47.30 M(-12.7%) | $324.81 M(+1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $54.18 M(-59.8%) | $319.09 M(+64.3%) |
| Dec 2015 | $194.17 M(+604.8%) | $134.94 M(+52.7%) | $194.17 M(+180.2%) |
| Sep 2015 | - | $88.38 M(+112.5%) | $69.31 M(-493.6%) |
| Jun 2015 | - | $41.58 M(-158.8%) | -$17.61 M(-58.5%) |
| Mar 2015 | - | -$70.74 M(-801.8%) | -$42.43 M(-254.0%) |
| Dec 2014 | $27.55 M(-150.7%) | $10.08 M(+587.5%) | $27.55 M(+337.8%) |
| Sep 2014 | - | $1.47 M(-91.3%) | $6.29 M(-236.3%) |
| Jun 2014 | - | $16.76 M(-2314.1%) | -$4.62 M(-85.7%) |
| Mar 2014 | - | -$757.00 K(-93.2%) | -$32.27 M(-40.5%) |
| Dec 2013 | -$54.29 M(-29.2%) | -$11.18 M(+18.4%) | -$54.29 M(-9.9%) |
| Sep 2013 | - | -$9.44 M(-13.4%) | -$60.28 M(-18.2%) |
| Jun 2013 | - | -$10.90 M(-52.1%) | -$73.66 M(-6.3%) |
| Mar 2013 | - | -$22.77 M(+32.6%) | -$78.62 M(+2.6%) |
| Dec 2012 | -$76.64 M(+84.5%) | -$17.17 M(-24.8%) | -$76.64 M(+3.5%) |
| Sep 2012 | - | -$22.83 M(+43.9%) | -$74.07 M(+9.7%) |
| Jun 2012 | - | -$15.86 M(-23.7%) | -$67.54 M(+21.0%) |
| Mar 2012 | - | -$20.79 M(+42.4%) | -$55.83 M(+34.4%) |
| Dec 2011 | -$41.54 M(+10.7%) | -$14.60 M(-10.4%) | -$41.54 M(+18.5%) |
| Sep 2011 | - | -$16.29 M(+292.8%) | -$35.07 M(+16.1%) |
| Jun 2011 | - | -$4.15 M(-36.2%) | -$30.21 M(-23.1%) |
| Mar 2011 | - | -$6.50 M(-20.1%) | -$39.26 M(+4.6%) |
| Dec 2010 | -$37.53 M(+104.1%) | -$8.13 M(-28.9%) | -$37.53 M(+11.3%) |
| Sep 2010 | - | -$11.43 M(-13.4%) | -$33.73 M(+26.7%) |
| Jun 2010 | - | -$13.20 M(+176.7%) | -$26.63 M(+48.1%) |
| Mar 2010 | - | -$4.77 M(+10.3%) | -$17.98 M(-2.2%) |
| Dec 2009 | -$18.39 M(-23.3%) | -$4.32 M(-0.3%) | -$18.39 M(+30.7%) |
| Sep 2009 | - | -$4.33 M(-4.8%) | -$14.07 M(+44.5%) |
| Jun 2009 | - | -$4.55 M(-12.0%) | -$9.73 M(+88.0%) |
| Mar 2009 | - | -$5.18 M | -$5.18 M |
| Dec 2008 | -$23.97 M | - | - |
FAQ
- What is Horizon Therapeutics Public Limited annual cash flow from operations?
- What is the all time high annual CFO for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited annual CFO year-on-year change?
- What is Horizon Therapeutics Public Limited quarterly cash flow from operations?
- What is the all time high quarterly CFO for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly CFO year-on-year change?
- What is Horizon Therapeutics Public Limited TTM cash flow from operations?
- What is the all time high TTM CFO for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited TTM CFO year-on-year change?
What is Horizon Therapeutics Public Limited annual cash flow from operations?
The current annual CFO of HZNP is $1.26 B
What is the all time high annual CFO for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual cash flow from operations is $1.26 B
What is Horizon Therapeutics Public Limited annual CFO year-on-year change?
Over the past year, HZNP annual cash flow from operations has changed by +$222.57 M (+21.50%)
What is Horizon Therapeutics Public Limited quarterly cash flow from operations?
The current quarterly CFO of HZNP is $161.47 M
What is the all time high quarterly CFO for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly cash flow from operations is $538.56 M
What is Horizon Therapeutics Public Limited quarterly CFO year-on-year change?
Over the past year, HZNP quarterly cash flow from operations has changed by -$87.73 M (-35.21%)
What is Horizon Therapeutics Public Limited TTM cash flow from operations?
The current TTM CFO of HZNP is $1.04 B
What is the all time high TTM CFO for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high TTM cash flow from operations is $1.41 B
What is Horizon Therapeutics Public Limited TTM CFO year-on-year change?
Over the past year, HZNP TTM cash flow from operations has changed by -$373.94 M (-26.43%)